(Q54592869)

1 June 2018

title

Evaluation of interleukin 13 polymorphisms in systemic sclerosis. (English)

1 reference

1 June 2018

author

Sandrine Marquet

6

1 reference

1 June 2018

Christophe Chevillard

object named as

Christophe Chevillard

2

0 references

Jean Gaudart

object named as

Jean Gaudart

13

0 references

author name string

Brigitte Granel

1

1 reference

1 June 2018

Yannick Allanore

3

1 reference

1 June 2018

Violaine Arnaud

4

1 reference

1 June 2018

Sandrine Cabantous

5

1 reference

1 June 2018

Pierre-Jean Weiller

7

1 reference

1 June 2018

Jean-Marc Durand

8

1 reference

1 June 2018

Jean-Robert Harlé

9

1 reference

1 June 2018

Claire Grange

10

1 reference

1 June 2018

Yves Frances

11

1 reference

1 June 2018

Philippe Berbis

12

1 reference

1 June 2018

Philippe de Micco

14

1 reference

1 June 2018

André Kahan

15

1 reference

1 June 2018

Alain Dessein

16

1 reference

1 June 2018

language of work or name

English

0 references

publication date

11 July 2006

1 reference

1 June 2018

published in

Immunogenetics

1 reference

1 June 2018

volume

58

1 reference

1 June 2018

issue

8

1 reference

1 June 2018

page(s)

693-699

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1007/s00251-006-0135-0

exact match

0 references

cites work

Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung

1 reference

https://api.crossref.org/works/10.1007%2FS00251-006-0135-0

Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL-13-591A/G polymorphisms and Schistosoma haematobium infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-006-0135-0

The C10/CCL6 chemokine and CCR1 play critical roles in the pathogenesis of IL-13-induced inflammation and remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-006-0135-0

IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-006-0135-0

IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts

21 January 2018

1 reference

12 December 2020

Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism

1 reference

12 December 2020

An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90)

1 reference

12 December 2020

Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020

Association between an interleukin-13 promoter polymorphism and atopy.

1 reference

12 December 2020

Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities

1 reference

12 December 2020

An IL-13 promoter polymorphism associated with increased risk of allergic asthma

1 reference

12 December 2020

Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis

1 reference

12 December 2020

Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays

1 reference

12 December 2020

The genetics of systemic sclerosis

1 reference

12 December 2020

An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response

1 reference

12 December 2020

Interleukin-13 in asthma

1 reference

12 December 2020

Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).

1 reference

12 December 2020

A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children

1 reference

12 December 2020

Criteria for the classification of early systemic sclerosis.

1 reference

12 December 2020

Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts

1 reference

12 December 2020

Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma

1 reference

12 December 2020

Fibrosis in scleroderma

1 reference

12 December 2020

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production

1 reference

12 December 2020

−238 and +489 TNF-α along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis

1 reference

12 December 2020

Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.

1 reference

12 December 2020

Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis

1 reference

12 December 2020

10.1007/S00251-006-0135-0

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018